Literature DB >> 30803496

Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health.

Matthew F Wipperman1, David C Montrose2, Antonio M Gotto3, David P Hajjar4.   

Abstract

The complex relationship between diet and metabolism is an important contributor to cellular metabolism and health. Over the past few decades, a central role for mammalian target of rapamycin (mTOR) in the regulation of multiple cellular processes, including the response to food intake, maintaining homeostasis, and the pathogenesis of disease, has been shown. Herein, we first review our current understanding of the biochemical functions of mTOR and its response to fluctuations in hormone levels, like insulin. Second, we highlight the role of mTOR in lipogenesis, adipogenesis, β-oxidation of lipids, and ketosis of carbohydrates, lipids, and proteins. Special attention is paid to recent advances in mTOR signaling in white versus brown adipose tissues. Finally, we review how mTOR regulates cardiovascular health and disease. Together, these insights define a clearer picture of the connection between mTOR signaling, metabolic health, and disease.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30803496      PMCID: PMC6412382          DOI: 10.1016/j.ajpath.2018.11.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  Differential metabolic sensitivity of insulin-like-response- and TORC1-dependent overgrowth in Drosophila fat cells.

Authors:  Maelle Devilliers; Damien Garrido; Mickael Poidevin; Thomas Rubin; Arnaud Le Rouzic; Jacques Montagne
Journal:  Genetics       Date:  2021-03-03       Impact factor: 4.562

Review 2.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

3.  Chronic everolimus treatment of high-fat diet mice leads to a reduction in obesity but impaired glucose tolerance.

Authors:  Geng-Ruei Chang; Po-Hsun Hou; Chao-Min Wang; Ching-Feng Wu; Huang-Kai Su; Huei-Jyuan Liao; To-Pang Chen
Journal:  Pharmacol Res Perspect       Date:  2021-04

Review 4.  PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

Authors:  Yan Peng; Yuanyuan Wang; Cheng Zhou; Wuxuan Mei; Changchun Zeng
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

5.  Palmitate Induces Mitochondrial Energy Metabolism Disorder and Cellular Damage via the PPAR Signaling Pathway in Diabetic Cardiomyopathy.

Authors:  Xianyu Zhang; Min Mao; Zhong Zuo
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-01       Impact factor: 3.249

6.  Hypoxia enhances ILC3 responses through HIF-1α-dependent mechanism.

Authors:  J L Fachi; L P Pral; J A C Dos Santos; A C Codo; S de Oliveira; J S Felipe; F F F Zambom; N O S Câmara; P M M M Vieira; M Colonna; M A R Vinolo
Journal:  Mucosal Immunol       Date:  2021-01-14       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.